ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 839

Occupational Exposures in Patients with Systemic Sclerosis Associated with Increased Frequency of Interstitial Lung Disease and Primary Pulmonary Hypertension

Brandi E. Stevens1,2, Mary Lucas3, Thomas A. Medsger Jr.4 and Robyn T. Domsic5, 1Division of Rheumatology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 2Medicine-Rheumatology, University of Pittsburgh, Pittsburgh, PA, 3Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, 4Department of Medicine/Rheumatology, University of Pittsburgh, Pittsburgh, PA, 5Medicine - Rheumatology, University of Pittsburgh, Pittsburgh, PA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Environmental factors, interstitial lung disease and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:
Systemic sclerosis (SSc) has been linked with environmental and occupational
exposures. Silica and solvent exposure have the strongest known correlation
with SSc. Other agents, notably aerosolized particles, may have a potential
role in pathogenesis. To date, there has been limited information on how these
exposures relate to disease phenotype. The objective of this study was to
evaluate associations between occupational exposures and SSc phenotypes.

Methods: We used a large,
prospectively enrolled, single-center SSc cohort for analysis.  At the first
visit, self-reported occupational exposure data is routinely collected. We
reviewed this occupational exposure data on all patients seen between January
1, 2000 and December 31, 2014. Exposure was categorized as: none, solvent,
silica/dust, other exposure (examples include fumes, aerosols), or ≥ 2
categories. We evaluated associations with disease phenotypes including
cutaneous subtype (diffuse vs. limited), serum autoantibody (anti-Scl70,
anti-RNA polymerase 3, anti-centromere and other) profile, and pulmonary involvement.
Pulmonary arterial hypertension (PAH) was defined as a mean pulmonary artery
pressure (PAP) > 25 mmHg on right heart catheterization or transthoracic
echocardiogram with PAP > 45mmHg and PAH diagnosed by a cardiologist.
Interstitial lung disease (ILD) required the presence of radiographic fibrosis.
Chi-square analysis was used to compare groups by exposure status.

Results: The total cohort (n=746)
was 78% female, 99% Caucasian and average age was 54 years. Of the 746 patients,
135 reported an occupational exposure. There were no differences between the exposed
and unexposed groups in age or race, although there were more males compared to
females in the exposed group (57% vs 14%, p <0.001). There was no
difference in exposure between cutaneous subtype or serum autoantibodies. ILD
was more frequent in the exposed (51%) vs. unexposed (37%) group (p=0.004).
Subanalysis of the exposed groups found individuals with dust/silica exposure
have a significantly higher rate of ILD than unexposed individuals (p=0.007).
There was no difference between the exposed and unexposed group in PAH prevalence
(p=0.29). However among the exposed group, those with “other” had a
markedly higher rate of PAH at 32% (p=0.01).

Table 1: Prevalence of PAH and ILD by Occupational Exposure Group

 

No Exposure

n=611

Solvent

n=47

Silica/Dust

n=46

Other Exposure

n=31

≥ 2 Exposures

n=11

Pulmonary arterial hypertension

64 (10.5%)

4(8.5%)

4 (8.7%)

10 (32.3%)

1 (9.1%)

Interstitial lung disease

228 (37.3%)

22 (46.8%)

27 (58.7%)

13 (41.9%)

7 (63.6%)

Conclusion: Males had
higher rates of occupational exposure. There was no relationship between
exposure and cutaneous or autoantibody subtype. Silica/dust exposure was
significantly associated with an increased frequency of ILD, whereas an
increased frequency of PAH was seen in those who reported an occupational
exposure that was not solvent or silica. These descriptive findings suggest
that further investigation into occupational exposures and relationship to
SSc-ILD and SSc-PAH is warranted.


Disclosure: B. E. Stevens, None; M. Lucas, None; T. A. Medsger Jr., None; R. T. Domsic, Biogen-Idec, 5,Bayer, 5.

To cite this abstract in AMA style:

Stevens BE, Lucas M, Medsger TA Jr., Domsic RT. Occupational Exposures in Patients with Systemic Sclerosis Associated with Increased Frequency of Interstitial Lung Disease and Primary Pulmonary Hypertension [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/occupational-exposures-in-patients-with-systemic-sclerosis-associated-with-increased-frequency-of-interstitial-lung-disease-and-primary-pulmonary-hypertension/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/occupational-exposures-in-patients-with-systemic-sclerosis-associated-with-increased-frequency-of-interstitial-lung-disease-and-primary-pulmonary-hypertension/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology